FindTrial
Sign In

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00876148
Enrollment
Unknown
Registered
2009-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2009-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allograft, Hematological Malignancies, Hepatitis B Virus

Keywords

Incidence of hepatitis B after allografting, Risk of hepatitis B reactivation, Lamivudine prophylaxis

Brief summary

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Interventions

None listed

Sponsors

Azienda Ospedaliera San Giovanni Battista
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* All patients undergoing an allograft for hematological malignancies

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026